Abstract
The practice of psychiatry is undergoing rapid and radical changes because of health care reorganization and the advances in basic science. Therefore, psychiatric educators must confront the redefinition of the role of the psychiatrist in the health care system. The model of the psychiatrist who primarily provides office-based psychotherapy is outmoded. Rather, the psychiatrist must become a clinical expert in brain and behavioral sciences, with mastery over an expanding array of diagnostic techniques and responsibility for directing integrated multidisciplinary treatment and rehabilitative services. To ensure this expertise, students must receive a firm grounding in neuroscience, molecular genetics, and brain imaging in addition to the traditional curriculum.
Similar content being viewed by others
References
Dorwart RA: Managed mental health care: myths and realities in the 1990s. Hospital and Community Psychiatry 1990; 41:1087–1091
Mirin SM: The changing face of mental health care: doing what’s needed, doing what’s right. Psychiatric Times 1993; 10:29–31
Kiesler CA, Sibulkin AE: Mental Hospitalization: Myths and Facts About a National Crisis. Newbury Park, CA, Sage Publications, 1987
Association of American Medical Colleges: National Resident Matching Program, NRMP Data, 1994. Washington, DC, Association of American Medical Colleges, 1994
Association of American Medical Colleges: American Medical Education, Institutions, Programs and Issues. Washington, DC, Association of American Medical Colleges, 1992
Olfson M, Pincus HA, Dial TH: Professional practice patterns of U.S. psychiatrists. Am J Psychiatry 1994; 151:89–95
Dorwart RA, Chartock LR, Dial T, et al: A national study of psychiatrists’ professional activities. Am J Psychiatry 1991; 149:1499–1505
Gabbard GO: The transition from residency to managed care nightmare. Academic Psychiatry 1992; 16:119–126
Hyman SE, Nestler EJ: The Molecular Foundations of Psychiatry. Washington, DC, American Psychiatric Press, 1993
Gusella JF, Wexler NS, Conneally PM, et al: A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 1983; 306:234–238
Huntington’s Disease Collaborative Research Group: a novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72:971–983
Institute of Medicine: Mapping the Brain and Its Functions. Washington, DC, National Academy Press, 1993
Baxter LR Jr, Schwartz JM, Bergman KS, et al: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:681–689
Cohen D, Chumokov I, Weissembach J: A first generation physical map of the human genome. Nature 1993; 366:698–701
Gershon ES, Cloninger CR: Genetic Approaches to Mental Disorders. Washington, DC, American Psychiatric Press, 1994
Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late-onset families. Science 1993; 261:921–923
Coyle JT, Price DL, DeLong MR: Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 1983; 219:1184–1190
Kosick KS: Alzheimer’s disease: a cell biological perspective. Science 1992; 256:780–783
Coyle JT, Oster-Granite ML, Reeves R, et al: Down syndrome and the trisomy 16 mouse: impact of gene imbalance on brain development and aging, in Genes, Brain and Behavior, edited by McHugh PR, McKusick V. New York, Raven, 1991, pp 85–99
Robinson MB, Coyle JT: Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J 1987; 1:446–455
Hyman S, Coyle JT: The neuroscientific foundations of psychiatry, in American Psychiatric Press Textbook of Psychiatry, 2nd Edition, edited by Hales RE, Yudofsky SC, Talbott JA. Washington, DC, American Psychiatric Press, 1994, pp 1–33
Seeman P, Guan HC, Van Tol HHM: Dopamine D-4 receptors elevated in schizophrenia. Science 1993; 365:441–45
Shenton ME, Kikinis R, Jolesz FA, et al: Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327:604–612
Shiino A, Matsuda M, Morikawa S, et al: Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993; 39:143–147
Wong DF, Wagner HN Jr, Tune LE, et al: Positron emission tomography reveals elevated D-2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234:1558–1563
Berman KF, Torrey EF, Danial JG, et al: Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992; 49:996–1001
Rauch SL, Jenike MA, Alpert NM, et al: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen-15 carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51:62–70
Rauch SL, Renshaw PF: Clinical neuroimaging in psychiatry. Harvard Review of Psychiatry 1995; 2:297–312
Falloon IRH, Boyd JL, McGill CW: Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry 1985; 42:887–896
Weissman MM, Markowitz JC: Interpersonal psychotherapy: current status. Arch Gen Psychiatry 1994; 51:599–606
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coyle, J.T. The Neuroscience Perspective and the Changing Role of the Psychiatrist. Acad Psychiatry 19, 202–212 (1995). https://doi.org/10.1007/BF03341546
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03341546